
Sign up to save your podcasts
Or
Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.
CME information and select publications here.
4.4
6262 ratings
Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.
CME information and select publications here.
139 Listeners
17 Listeners
32 Listeners
14 Listeners
13 Listeners
71 Listeners
0 Listeners
322 Listeners
111 Listeners
507 Listeners
61 Listeners
282 Listeners
3,338 Listeners
195 Listeners
516 Listeners
60 Listeners
181 Listeners
0 Listeners